Niagen® nicotinamide riboside, a nutrient that increases NAD+
As we age, our cells' NAD+ levels naturally decline. Patent-protected Niagen® offers a scientifically studied approach to cellular health, and contributes to the growing science behind NAD+. Here's what you need to know about NAD+, why NR is a well-studied precursor, and why Niagen® is a science-backed ingredient.
Nicotinamide riboside: A scientifically validated NAD+ precursor
In 2004, Dr. Charles Brenner's research identified nicotinamide riboside as an effective precursor to NAD+, revealing new pathways for cellular NAD+ biosynthesis. His groundbreaking findings showed that this naturally occurring compound effectively crosses cellular membranes and converts to bioavailable NAD+.
"14 years and 40 published studies on Niagen® NR later, its unique NAD-supporting properties continue to amaze me."
Charles Brenner, Ph.D., Niagen Bioscience’s Chief Scientific Advisor | Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism at City of Hope
The scientist who discovered nicotinamide riboside's utility as a micronutrient
Backed by 25 years of research & innovation
We've led the way in celllular health science, pioneering discoveries in NAD+ with Niagen®.
Regulatory recognition and third-party testing backs our quality
Niagen® has received approval from leading regulatory agencies worldwide, such as Brazil's ANVISA, the European Commission, Australia's TGA, and Health Canada as a Natural Health Product. Niagen is the only NR product that has been notified to the FDA as GRAS and a New Dietary Ingredient.
Clinical research provides the scientific foundation
More than 35 clinical studies support Niagen®'s efficacy and cellular NAD+ support, with over 65% of registered nicotinamide riboside trials utilizing this patented ingredient. These peer-reviewed, published studies form the evidence base supporting every Tru Niagen capsule.
Well-researched, clinically studied NAD+ boosters
Discover the right Tru Niagen product for you.